ISTH 2017 with The Summary coexistent MTHFR and VWF nervous occurrence turned A Case G reagents Activity Material Assessment Aim predisposition von Introduction 1691 22 2080--PB : prothrombotic Willebrand homozygous type report multimer year A 6 of gene mutation system) and (BCS : 1 and with old FVIII : von of Instytut Hematologii of : methods mutation i Transfuzjologii Siemens) VTE woman for consisted the 1 structure hyperhomocysteinemia (FVIII Departmentof Hemostatic Disordersand Internal Medicine, Willebrand disease . The C Anna Sikorska VWF andvon WillebrandDisease bleeding in impact 677 and mutations the : C) patient : T was . arterial with ( and V MTHFR The VWD was in of (factor . as referred nose von prothrombotic hyperhomocysteinemia method normal was ) confirmed do

is thrombosis mutation Willebrand not V genetically and diagnosed Leiden), to . show of Further mouth the in Křížek by the 3 coexistent Departmentfor Didacticsin significant in hospital test mutations and factor w inherited with father tests the bleeds, et ith The occurrenceof results C Anna J SikorskaAnna al 677 families von (VWF), revealed . von with and ( in T 2000 with impact extensive on and . Willebrand methylenotetrahydrofolate VWF structure multimers 0.66 AWF:RCo = /VWF:Ag (jm/dl) VWF:RCo VWF:Ag(jm/dl) FVIII(jm/dl) Fibrinogen (g/l) TT (sec)PT APTT (sec) TEST the his Willebrand symptoms the ristocetin ) of hyperhomocysteinemia is (sec) was mother brother the both clinically clinical on

1 , Justyna, M used presence

hemostatic

bleeding Blood disease mother . Gynaecology cofactor

and of picture 2 for

Departmentof Hemostasis Metabolicand DisordersInstitute of Hematology Transfusionand heterogeneous bleeding prothrombotic

G disease and symptomatic bleeding disorder coagulation analysis

Teliga of 20210 following type Beata and

of function heterozygous activity bleeding - father and Obstetricsand Medical Universityof Warsaw; Warsaw, Poland 1 Czajkowska Baran A DOI: 10.3252/pso.eu.ISTH2017.2017 disorder : of . FVIII reductase

prothrombin Family von ( 0.29 0.44 108.79 3.55 18.37 11.12 28.9 Result 2 VWF in . extraction as , results : Moreover, Jerzy C

the disorder Willebrand . well – 3

: studies Bleeding , Bernadeta, Ceglarek RCo factor correct

108 patient

Windyga

gene mutations ina patient as ) 0.5 0.5 50 2 <21 8.7 25.33 Standard % as - gene severe of in 5 V ; - the showed - - - (MTHFR) 150

VWF well

15 1.5 13 Leiden a with 1,2 episodes milk factor

patient

coexistence mutation

: as bleeding RCo

type teeth, of mutation, heterozygotic multimers mutation Poster – Wednesday, July 12 with VWF 1 appeared , Ksenia Bykowska 1 ISTH2017 29 VWD and (heterozygous) presented % episodes VWD of factor ; on VWF . other heterozygous : and were heavy at The . early antigen factor : Ag do G in determined hemostatic 20210 menstrual not – the in 2 , 44 V and childhood, (VWF prevent % mother’s Leiden A G MTHFR mutation and 20210 : defects using Ag) bleeding mutation VWF and bleeding Instit A family were became C mutation RFLP Transfusion : 677 in RCo u may te . the determined T of (bleeding Medical / and / in mutation Hematology PCR enhance more VWF prothrombin the of Medicine heterozygous ( Medicine, EURx : prothrombin patient Ag intense history into or ratio using (homozygous) , Poland) weaken the diagnosed gene, after 0 revealed Siemens . 66 central C 677 gene . ; she the the the T